NVTA Invitae Corp.

22.10-1.00 (-4.33%)
Close: February 24, 2020

22.450.35 (+1.58%)
After hours

Quote

Previous Close
$22.10
Day Range
$21.41-$22.52
52 Week Range
$14.35-$28.75
Volume
4,417,566
Avg Volume
3,674,558
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$2.17B
Enterprise Value (EV)
$2.19B
PE Ratio
-
EV/EBITDA
-9.61
Price/Sales
10.44
Price/Book
5.70
PEG Ratio
0.15

Financials

Revenue
$216.82M
Gross Profit
$95.44M
EBITDA
-$227.91M
EPS, ttm
-$2.62
Profit Margin
-
Revenue/Employee
-
Next Earnings Date
5/11/2020 (76 days)
Debt to Equity
84%
Debt
$416.81M
Cash
$391.83M
Net Debt
$24.99M

Performance

Beta
2.17
200 Day Moving Avg
$20.32
50 Day Moving Avg
$19.25
52 Week Change
19.69%
YTD Change
36.52%
1 Month Change
23.20%
3 Month Change
17.74%
6 Month Change
-12.67%
1 Year Change
23.93%
2 Year Change
264.93%
5 Year Change
17.02%

Share Count

Shares Outstanding
98.0M
Float
93.3M
Restricted Shares
4.7M
Restricted Shares, %
4.77%

Invitae Corp. Company Details

Sector: Health Services

Industry: Medical/Nursing Services

CEO: Sean Emerson George

Website: http://www.invitae.com

Description: Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.

Employees: -